๐ ๐๐๐ฌ๐ฎ๐ฅ๐ญ๐ฌ
โข Non-GAAP EPS: $2.80 (+27.9% YoY)
โข EPS: $2.29 (+26.5% YoY)
โข Revenue: $2.89B (+19% YoY)
โข Non-GAAP Operating Income: $1.22B, up from $950M
โข Instruments and Accessories Revenue: $1.73B (+18% YoY)
โ
๐ฏ ๐๐ฎ๐ข๐๐๐ง๐๐
โข FY2026 da Vinci Procedure Growth: +13.5% to +15.5%, expected near the midpoint
โข FY2026 Non-GAAP Gross Margin: 68%โ69%
โข FY2026 Non-GAAP Operating Expense Growth: 11%โ13%
โข Gross margin outlook includes an estimated tariff impact equal to 1% of revenue
โ
๐ ๐๐๐ฒ ๐๐๐ค๐๐๐ฐ๐๐ฒ๐ฌ
โข Combined da Vinci and Ion procedures grew approximately 16%, with Ion procedures up 36%
โข Placed 468 da Vinci systems, including 246 da Vinci 5 systems, and 55 Ion systems
โข da Vinci installed base increased 12% to 11,710 systems, while Ion grew 21% to 1,096
โข Cash and investments increased to $8.63B, while $380M was deployed for share repurchases
โข Results included a $0.08 per-share benefit from prior-period tariff refunds
โ
๐ฌ ๐๐๐ง๐๐ ๐๐ฆ๐๐ง๐ญ ๐๐จ๐ฆ๐ฆ๐๐ง๐ญ๐๐ซ๐ฒ
โWe are pleased with company performance this quarter, which reflects the strength of our portfolio, from da Vinci and Ion to our growing digital solutions.โ
